Viewing Study NCT03400332


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2026-07-09 @ 9:11 PM
Study NCT ID: NCT03400332
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-25
First Post: 2018-01-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Melanoma View
Keywords: